Aehr Test Systems (NASDAQ:AEHR) Price Target Cut to $140.00 by Analysts at Jefferies Financial Group

Key Points

• Jefferies cut its price target on Aehr Test Systems from $175 to $140 but maintained a Buy rating; the new target implies 119.52% upside from the prior close.
• Aehr reported fiscal first-quarter revenue of $33.0 million and EPS of $0.28, both above analyst estimates, and raised its fiscal 2027 revenue outlook to $150 million.
• The company cited an effective backlog of $109.3 million as of November 1 in support of its stronger outlook; analysts’ consensus rating is Moderate Buy, with an average target of $118.75.

Aehr Test Systems (NASDAQ:AEHR - Get Free Report) had its price objective dropped by analysts at Jefferies Financial Group from $175.00 to $140.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage presently has a "buy" rating on the semiconductor company's stock. Jefferies Financial Group's target price suggests a potential upside of 119.52% from the stock's previous close.

A number of other equities analysts also recently weighed in on the stock. Craig Hallum reaffirmed a "buy" rating and set a $125.00 target price on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Oppenheimer initiated coverage on Aehr Test Systems in a research note on Thursday, September 10th. They set an "outperform" rating and a $120.00 price objective for the company. Wall Street Zen raised Aehr Test Systems from a "sell" rating to a "hold" rating in a report on Saturday, July 18th. Lake Street Capital cut their target price on Aehr Test Systems from $110.00 to $90.00 and set a "buy" rating on the stock in a research note on Tuesday. Finally, Weiss Ratings restated a "sell (e+)" rating on shares of Aehr Test Systems in a report on Tuesday, October 27th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Aehr Test Systems presently has an average rating of "Moderate Buy" and a consensus target price of $118.75.

Aehr Test Systems Stock Performance

Shares of NASDAQ AEHR traded up $12.30 during mid-day trading on Tuesday, hitting $63.77. 7,188,536 shares of the stock traded hands, compared to its average volume of 2,506,228. Aehr Test Systems has a 52 week low of $18.70 and a 52 week high of $147.40. The company has a market cap of $2.08 billion, a price-to-earnings ratio of -265.59 and a beta of 3.47. The stock has a fifty day moving average price of $82.66 and a 200-day moving average price of $73.90.

Aehr Test Systems (NASDAQ:AEHR - Get Free Report) last released its earnings results on Monday, November 2nd. The semiconductor company reported $0.28 earnings per share for the quarter, topping analysts' consensus estimates of $0.11 by $0.17. Aehr Test Systems had a negative net margin of 14.25% and a negative return on equity of 3.83%. The firm had revenue of $33.01 million for the quarter, compared to the consensus estimate of $27.53 million. As a group, sell-side analysts predict that Aehr Test Systems will post 0.45 EPS for the current fiscal year.

Insider Buying and Selling at Aehr Test Systems

In other Aehr Test Systems news, EVP Alberto Salamone sold 9,672 shares of the company's stock in a transaction dated Thursday, August 13th. The stock was sold at an average price of $127.72, for a total value of $1,235,307.84. Following the completion of the sale, the executive vice president owned 41,962 shares in the company, valued at $5,359,386.64. This represents a 18.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, COO Adil Engineer sold 15,000 shares of the stock in a transaction that occurred on Wednesday, August 12th. The stock was sold at an average price of $131.02, for a total transaction of $1,965,300.00. Following the completion of the sale, the chief operating officer directly owned 46,977 shares of the company's stock, valued at $6,154,926.54. This represents a 24.20% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 87,475 shares of company stock worth $11,459,240. 4.60% of the stock is owned by corporate insiders.

Institutional Trading of Aehr Test Systems

Hedge funds and other institutional investors have recently modified their holdings of the company. Advocate Investing Services LLC bought a new stake in shares of Aehr Test Systems during the 2nd quarter valued at $26,000. Nykredit A S bought a new position in Aehr Test Systems in the 2nd quarter worth $28,000. KBC Group NV bought a new stake in Aehr Test Systems during the first quarter valued at about $30,000. Compagnie Lombard Odier SCmA bought a new stake in Aehr Test Systems during the second quarter valued at about $34,000. Finally, Tema ETFs LLC purchased a new position in shares of Aehr Test Systems in the second quarter valued at about $89,000. 69.69% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Aehr Test Systems

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Fiscal Q1 revenue reached a record $33.0 million, ahead of the $27.5 million consensus, while reported EPS of $0.28 also topped estimates. The company attributed growth to strong semiconductor demand, including AI-related demand. Article: AEHR Q1 Earnings Beat Estimates on AI Demand, Revenue Outlook Raised
• Positive Sentiment: Aehr raised fiscal 2027 revenue guidance to $150 million—above the $138.4 million analyst consensus and roughly triple fiscal 2026 revenue. Effective backlog stood at $109.3 million as of November 1, supporting the stronger outlook. Article: Aehr Test Systems: 3 Key Takeaways for Long-Term Investors
• Neutral Sentiment: Call-option activity was unusually high, with traders buying about 14,866 contracts—approximately 51% above typical volume. This signals increased trading interest but does not establish the direction of future performance.

About Aehr Test Systems

Aehr Test Systems NASDAQ: AEHR develops and manufactures test and burn-in equipment used to qualify and screen semiconductor devices. Its systems are designed to identify manufacturing defects and reliability issues before chips are shipped to customers, helping semiconductor manufacturers improve production yields and product quality.

The company's product portfolio includes the FOX family of semiconductor test systems, including the FOX-XP, FOX-NP and FOX-1P platforms. Aehr also provides wafer contactors, DiePak carriers and related test fixtures and software.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.